Diabetes Self-Management Blog

A working group composed of researchers, clinical endocrinologists, and primary-care doctors convened by the Endocrine Society has recommended that greater emphasis be placed on regularly screening people at risk for Type 2 diabetes and promptly and aggressively treating those who have developed the condition in an attempt to preserve beta cell function. Roughly 24 million people in the United States have been diagnosed with Type 2 diabetes, and another 57 million are thought to have prediabetes.

Studies in both humans and animals have indicated that Type 2 diabetes involves dysfunctional beta cells (the insulin-producing pancreatic cells) that are not able to produce enough insulin to overcome increasing insulin resistance, another characteristic of Type 2. This failure of the beta cells appears to occur early in the progression of the disease. However, accumulating evidence indicates that the reduction in beta cell function could be slowed or potentially reversed, particularly if addressed early.

According to Jack L. Leahy, MD, one of the statement’s authors, “There is widespread evidence that the conventional approaches to the management of Type 2 diabetes have been inadequate… The increasing recognition that beta-cell failure occurs much earlier and [more] severely than commonly believed suggests that regular glycemia screening, early identification of patients at metabolic risk, and prompt and aggressive intervention deserves greater emphasis.”

The working group also recommended that researchers initiate studies to determine the usefulness of drug therapies that specifically target beta cell function.

To learn more about the recommendations, see the article “Experts Advocate Realigning Type 2 Diabetes Treatments With Disease’s Natural History” or read the consensus statement’s abstract in the Journal of Clinical Endocrinology and Metabolism. And for more information about Type 2 diabetes, click here.

POST A COMMENT       
  

We are currently experiencing technical difficulties with our commenting system. Thank you for your patience as we work to resolve them.


Diabetes Research
Sweet-Smelling Breath Holds Promise as Tool for Diagnosing Diabetes (12/12/14)
Painkiller Linked to Low Blood Sugar (12/11/14)
Battling Food Cravings? Try These Strategies. (11/21/14)
A Diabetes Cure in Mice (11/13/14)

Diabetes News
Sweet-Smelling Breath Holds Promise as Tool for Diagnosing Diabetes (12/12/14)
Painkiller Linked to Low Blood Sugar (12/11/14)
Neuropathy Medicine Recalled; Animas Vibe System Approved (12/05/14)
Battling Food Cravings? Try These Strategies. (11/21/14)

Diane Fennell
Sweet-Smelling Breath Holds Promise as Tool for Diagnosing Diabetes (12/12/14)
Painkiller Linked to Low Blood Sugar (12/11/14)
Neuropathy Medicine Recalled; Animas Vibe System Approved (12/05/14)
Battling Food Cravings? Try These Strategies. (11/21/14)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.